Finnrick - Ensuring a Safer and More Transparent Supply Chain
Wuhan Wansheng Biotechnology

Wuhan Wansheng Biotechnology

Finnrick has tested 56 samples from Wuhan Wansheng Biotechnology across 3 products.

Finnrick Vendor Profile
to
C
E
Wuhan Wansheng Biotechnology
Tracking 3 products
56 total samples tested
Last test 25 Nov 2025

Take Action

Test My Sample
Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Products

Tests
Product
Rating
CountAvgMinMaxOldestMost Recent
Retatrutide
C
Okay
347.34.610.04 Aug 202525 Nov 2025
Tesamorelin
E
Bad
84.91.17.811 Aug 202525 Nov 2025
Tirzepatide
E
Bad
146.82.89.931 Aug 20254 Nov 2025

Most recent Wuhan Wansheng Biotechnology tests

Samples are tested in commercial labs

56

tests

3

products

Scores

AVG6.9MIN1.1MAX10.0

First

4 Aug 2025

Last

25 Nov 2025
Quantity
Test DateProductCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
25 Nov 2025TesamorelinView5.410mg9.080mg-9.2%71.37%1Tes10PDWhite Label / Silver Crimp / White Cap Lab EPublic
25 Nov 2025RetatrutideView8.030mg30.100mg+0.3%99.95%(no batch ID)No Label / Silver Crimp / Clear Yellow Cap Lab EPublic
25 Nov 2025TesamorelinView1.110mg5.070mg-49.3%47.46%(no batch ID)(no data)Lab EPublic
25 Nov 2025RetatrutideView10.050mg47.600mg-4.8%99.95%wwb-25-11White Label / Black Crimp / Clear Blue CapLab EPublic
18 Nov 2025RetatrutideView7.420mg17.000mg-15.0%99.80%July 15 2025No Label / Silver Crimp / Violet CapLab EPublic
17 Nov 2025RetatrutideView7.130mg28.100mg-6.3%99.72%(no batch ID)No Label / Silver Crimp / Clear Yellow CapLab EPublic
4 Nov 2025RetatrutideView8.020mg20.700mg+3.5%99.90%(no batch ID)Silver Label / Silver Crimp / Violet CapLab GPublic

Corrections

5 Nov 2025: Retatrutide
These were remade and reanalyzed by Lab G. They traced the discrepancy to a likely human error during preparation.